Nomad Foods

NOMD · NYSE

$12.00−$0.23 (−1.88%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $12.23

NOMD analyst rating

BuyConsensus of 4 analysts over the last 12 months. 75% rate it a buy.

Strong buy0
Buy3
Hold1
Underperform0
Sell0

12-month price target · 7 analysts

Average $14.08 (+17.3% upside)

Low: $12.12
Now: $12.00
High: $15.75

Upgrades and downgrades

The latest rating actions, newest first

NOMD analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
BTIG	Oct 8, 2026	Maintains	Buy	$15.00	55%
BTIG	Aug 14, 2026	Maintains	Buy	$15.00	55%
Barclays	Jul 21, 2026	Maintains	Overweight	$12.00 → $14.00	50%
BTIG	May 13, 2026	Maintains	Buy	$15.00	55%
Barclays	Apr 15, 2026	Maintains	Overweight	$13.00 → $12.00	50%
Deutsche Bank	Mar 30, 2026	Downgrade	Buy → Hold	$15.00 → $10.00	62%
Mizuho	Mar 3, 2026	Maintains	Outperform	$15.00 → $13.00	50%
Barclays	Mar 2, 2026	Maintains	Overweight	$15.00 → $13.00	50%
BTIG	Mar 2, 2026	Maintains	Buy	$18.00 → $15.00	55%
Mizuho	Jan 8, 2026	Maintains	Outperform	$17.00 → $15.00	50%

The case for and against

Updated Oct 18, 2026

Bull case

Nomad Foods is supported by a leading branded frozen-food portfolio across Western Europe, with strong positions in Birds Eye, Findus, and Iglo, and exposure to health-oriented categories such as fish, vegetables, proteins, and prepared meals. Despite recent volume pressure, management is attacking the decline with category expansion, channel diversification, and a leaner marketing structure, while 2Q26 revenue, adjusted EBITDA, and EPS all came in slightly ahead of expectations and gross margin reached 28.7%. The outlook is further strengthened by €180MM-€200MM of COGS productivity savings expected over 2027-2029, disciplined pricing to offset 7% inflation next year, and a greater emphasis on free cash flow, capital returns, and margin recovery.

Bear case

Nomad Foods is facing a negative outlook because sales are weakening, with total revenue declines of 2.2%, 3.2%, and 3.4% tied mainly to volume drops of 3.8%, 4.7%, and 2.6%, showing that recent pricing actions have not offset demand pressure. Operating leverage is also deteriorating, as higher incentive compensation and advertising/promotional spending, plus inflation—especially in fish—have pushed operating margin down to 12.6% to 12.9% and reduced adjusted EBITDA to about €477.7MM to €489.1MM. Although management is pursuing efficiencies, the combination of sustained volume declines, retailer resistance to further price increases, and the stock’s prior earnings-driven rerating suggests the business needs clear execution and stronger organic growth before sentiment can improve.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.